Keyphrases
Thymus
85%
Medullary Thymic Epithelial Cells (mTECs)
76%
T Cells
68%
Autoimmune Regulator
66%
CpG-C
50%
Natural Killer Cells
44%
Natural Killer Cell Cytotoxicity
39%
Master Regulator
38%
Immunological Tolerance
38%
MHC Class II
38%
Staphylococcal Enterotoxins
38%
Self-tolerance
37%
Mediating Mechanism
35%
Metastatic Dissemination
33%
Aire
33%
CD4+
33%
Superantigen
33%
Cell Function
33%
Tumor Metastasis
33%
Treg
29%
Mouse Model
28%
Immunosuppression
28%
Autoimmune Polyendocrine Syndrome Type 1 (APS-1)
27%
Immune System
25%
Cancer Patients
25%
Deleterious Effects
24%
Leukocytes
24%
Recurrence-free Survival
23%
Lung Tumor
23%
Tumor Necrosis Factor-α
22%
Metastasis
22%
Tumor Retention
21%
Long-term Recurrence
20%
Autoimmune Regulator Gene
20%
Transcriptional Regulation
19%
Cellular Immunity
19%
Transcriptional Program
19%
Interleukin-12 (IL-12)
19%
Prophylactic Treatment
19%
Adrenoceptors
19%
Etodolac
19%
Beta-blockers
19%
Behavioral Response
18%
In Cancer
18%
Immune Stimulation
18%
T Helper 17 (Th17)
16%
Interleukin-18 (IL-18)
16%
Cell-mediated Immune Response
16%
FOXN1
16%
Tuft Cells
16%
Immunology and Microbiology
Autoimmune Regulator
100%
Immune Tolerance
97%
Thymus
97%
T Cell
81%
Natural Killer Cell
65%
Immunostimulation
50%
Gene Expression
42%
Autoimmune Polyendocrine Syndrome Type 1
41%
Mouse
41%
Cytotoxicity
36%
Immune Response
35%
CD4
33%
Cell Function
33%
Cytokine
31%
Cell Differentiation
30%
Autoregulation
25%
Regulatory T Cell
25%
Mouse Model
25%
Immune System
23%
Adoptive Immunity
23%
Blood Plasma
22%
Innate Lymphoid Cell
20%
Enterotoxin
20%
Leukocyte
20%
Superantigen
20%
Exon
19%
Immunosuppression
19%
Regulator Gene
19%
Lymphoid Organ
19%
Physiological Stress
19%
Mental Stress
19%
Autoimmunity
18%
Fischer 344 Rat
17%
Fibroblast
16%
Segmented Filamentous Bacteria
16%
Cell Expansion
16%
T Helper 17 Cell
16%
Immunotherapy
16%
Cancer Cell
16%
Candida Albicans
16%
Cell Maturation
16%
Demethylation
16%
Recurrence Free Survival
16%
Transcription Factors
16%
Immunoglobulin M
16%
Promoter Region
16%
Cell Heterogeneity
16%
Cytokine Response
16%
Glucocorticoid
16%
C57BL 6 Mouse
14%
Medicine and Dentistry
Metastatic Carcinoma
65%
Natural Killer Cell
64%
Cytotoxicity
55%
Immunosuppressive Treatment
45%
Immunostimulation
38%
Epithelial Cell
33%
Neoplasm
26%
Adrenergic Receptor
25%
Leukocyte
23%
Recurrence Free Survival
23%
Surgical Stress
20%
Cellular Immunity
17%
Cancer Cell
16%
Breast Cancer
16%
Cell Function
16%
Oligodeoxynucleotide
16%
Cell Maturation
16%
Immunological Tolerance
16%
Cytokine
16%
Perioperative Period
16%
Catecholamine
16%
Primary Tumor
15%
Prostaglandin
14%
Malignant Neoplasm
13%
Glucocorticoid
12%
Survival Rate
11%
Breast Adenocarcinoma
10%
Etodolac
10%
Thymus
10%
Long Term Survival
9%
Surgical Technique
8%
Surgery
8%
Lung Tumor
8%
In Vitro
8%
Melanoma B16
8%
Recurrent Disease
7%
Propranolol
6%
Melanoma Cell
6%
T Cell
6%
Physiological Stress
6%
Infection
5%
Tissue Injury
5%
Minimal Residual Disease
5%
Postoperative Period
5%
Human Study
5%
Polyinosinic Polycytidylic Acid
5%
Healthcare Practitioner
5%
Cellular Mechanism
5%
Immunocompetence
5%
